Drug Shortage Report for APO-TADALAFIL
Report ID | 15409 |
Drug Identification Number | 02422085 |
Brand name | APO-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 BLS |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-07-10 |
Estimated end date | 2017-12-28 |
Actual end date | 2017-12-06 |
Shortage status | Resolved |
Updated date | 2017-12-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2017-12-07 | French | Compare |
v9 | 2017-12-07 | English | Compare |
v8 | 2017-10-17 | French | Compare |
v7 | 2017-10-17 | English | Compare |
v6 | 2017-09-25 | French | Compare |
v5 | 2017-09-25 | English | Compare |
v4 | 2017-07-31 | French | Compare |
v3 | 2017-07-31 | English | Compare |
v2 | 2017-07-11 | French | Compare |
v1 | 2017-07-11 | English | Compare |
Showing 1 to 10 of 10